ArticleMolecular cancer research : MCR2022

MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer.

Jia-Ying Lloyd Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.